190 related articles for article (PubMed ID: 24980157)
1. Absence of caveolin-1 expression in carcinoma-associated fibroblasts of invasive micropapillary carcinoma of the breast predicts poor patient outcome.
Ren M; Liu F; Zhu Y; Li Y; Lang R; Fan Y; Gu F; Zhang X; Fu L
Virchows Arch; 2014 Sep; 465(3):291-8. PubMed ID: 24980157
[TBL] [Abstract][Full Text] [Related]
2. Invasive micropapillary carcinoma of the breast has a better long-term survival than invasive ductal carcinoma of the breast in spite of its aggressive clinical presentations: a comparison based on large population database and case-control analysis.
Chen H; Wu K; Wang M; Wang F; Zhang M; Zhang P
Cancer Med; 2017 Dec; 6(12):2775-2786. PubMed ID: 29072365
[TBL] [Abstract][Full Text] [Related]
3. Comparison of invasive micropapillary and triple negative invasive ductal carcinoma of the breast.
Chen HL; Ding A
Breast; 2015 Dec; 24(6):723-31. PubMed ID: 26392199
[TBL] [Abstract][Full Text] [Related]
4. The relationship between the expressions of tumor associated fibroblasts Cav-1 and MCT4 and the prognosis of papillary carcinoma of breast.
Zhai Y; Chai L; Chen J
Pak J Pharm Sci; 2017 Jan; 30(1 Suppl):263-272. PubMed ID: 28625953
[TBL] [Abstract][Full Text] [Related]
5. Population-based comparison of prognostic factors in invasive micropapillary and invasive ductal carcinoma of the breast.
Chen AC; Paulino AC; Schwartz MR; Rodriguez AA; Bass BL; Chang JC; Teh BS
Br J Cancer; 2014 Jul; 111(3):619-22. PubMed ID: 24921921
[TBL] [Abstract][Full Text] [Related]
6. Invasive micropapillary carcinoma of the breast had no difference in prognosis compared with invasive ductal carcinoma: a propensity-matched analysis.
Hao S; Zhao YY; Peng JJ; Ren F; Yang WT; Yu KD; Shao ZM
Sci Rep; 2019 Jan; 9(1):286. PubMed ID: 30670771
[TBL] [Abstract][Full Text] [Related]
7. Invasive micropapillary carcinoma of the breast had poor clinical characteristics but showed no difference in prognosis compared with invasive ductal carcinoma.
Li G; Yang S; Yao J; Wang Z; Yao G; Liu M; Ye C
World J Surg Oncol; 2016 Aug; 14(1):207. PubMed ID: 27492008
[TBL] [Abstract][Full Text] [Related]
8. [The comparison of characters between invasive micropapillary carcinoma and invasive ductal carcinoma not otherwise specified of the breast].
Hua B; Lu X; Xiao WZ; He SR; Wang Z
Zhonghua Wai Ke Za Zhi; 2017 Oct; 55(10):770-774. PubMed ID: 29050179
[No Abstract] [Full Text] [Related]
9. Increased expression of CD146 and microvessel density (MVD) in invasive micropapillary carcinoma of the breast: Comparative study with invasive ductal carcinoma-not otherwise specified.
Li W; Yang D; Wang S; Guo X; Lang R; Fan Y; Gu F; Zhang X; Niu Y; Yan X; Fu L
Pathol Res Pract; 2011 Dec; 207(12):739-46. PubMed ID: 22051146
[TBL] [Abstract][Full Text] [Related]
10. Clinico-pathological features and prognosis of invasive micropapillary carcinoma compared to invasive ductal carcinoma: a population-based study from China.
Shi WB; Yang LJ; Hu X; Zhou J; Zhang Q; Shao ZM
PLoS One; 2014; 9(6):e101390. PubMed ID: 24977705
[TBL] [Abstract][Full Text] [Related]
11. Differences in prognostic factors and patterns of failure between invasive micropapillary carcinoma and invasive ductal carcinoma of the breast: matched case-control study.
Yu JI; Choi DH; Park W; Huh SJ; Cho EY; Lim YH; Ahn JS; Yang JH; Nam SJ
Breast; 2010 Jun; 19(3):231-7. PubMed ID: 20304650
[TBL] [Abstract][Full Text] [Related]
12. The clinicopathological significance of CD44+/CD24-/low and CD24+ tumor cells in invasive micropapillary carcinoma of the breast.
Li W; Liu F; Lei T; Xu X; Liu B; Cui L; Wei J; Guo X; Lang R; Fan Y; Gu F; Tang P; Zhang X; Fu L
Pathol Res Pract; 2010 Dec; 206(12):828-34. PubMed ID: 20977976
[TBL] [Abstract][Full Text] [Related]
13. Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer.
Mercogliano MF; Inurrigarro G; De Martino M; Venturutti L; Rivas MA; Cordo-Russo R; Proietti CJ; Fernández EA; Frahm I; Barchuk S; Allemand DH; Figurelli S; Deza EG; Ares S; Gercovich FG; Cortese E; Amasino M; Guzmán P; Roa JC; Elizalde PV; Schillaci R
BMC Cancer; 2017 Dec; 17(1):895. PubMed ID: 29281999
[TBL] [Abstract][Full Text] [Related]
14. The prognosis of invasive micropapillary carcinoma compared with invasive ductal carcinoma in the breast: a meta-analysis.
Wu Y; Zhang N; Yang Q
BMC Cancer; 2017 Dec; 17(1):839. PubMed ID: 29228910
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic study of invasive micropapillary carcinoma of the breast.
Tang SL; Yang JQ; Du ZG; Tan QW; Zhou YT; Zhang D; Lv Q
Oncotarget; 2017 Jun; 8(26):42455-42465. PubMed ID: 28418916
[TBL] [Abstract][Full Text] [Related]
16. [PSCA expression in invasive micropapillary carcinoma of breast].
Hao JY; Yang YL; Li S; Qian XL; Liu FF; Fu L
Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):382-6. PubMed ID: 21914346
[TBL] [Abstract][Full Text] [Related]
17. Invasive micropapillary carcinoma of the breast: a clinicopathologic study of 103 cases of an unusual and highly aggressive variant of breast carcinoma.
Gokce H; Durak MG; Akin MM; Canda T; Balci P; Ellidokuz H; Demirkan B; Gorken IB; Sevinc AI; Kocdor MA; Saydam S; Harmancioglu O
Breast J; 2013; 19(4):374-81. PubMed ID: 23714006
[TBL] [Abstract][Full Text] [Related]
18. Breast carcinoma with micropapillary features: clinicopathologic study and long-term follow-up of 100 cases.
Chen L; Fan Y; Lang RG; Guo XJ; Sun YL; Cui LF; Liu FF; Wei J; Zhang XM; Fu L
Int J Surg Pathol; 2008 Apr; 16(2):155-63. PubMed ID: 18417672
[TBL] [Abstract][Full Text] [Related]
19. Prognosis of invasive micropapillary carcinoma compared with invasive ductal carcinoma in breast: A meta-analysis of PSM studies.
Ye F; Yu P; Li N; Yang A; Xie X; Tang H; Liu P
Breast; 2020 Jun; 51():11-20. PubMed ID: 32172190
[TBL] [Abstract][Full Text] [Related]
20. Differences in Prognostic Factors and Failure Patterns Between Invasive Micropapillary Carcinoma and Carcinoma With Micropapillary Component Versus Invasive Ductal Carcinoma of the Breast: Retrospective Multicenter Case-Control Study (KROG 13-06).
Yu JI; Choi DH; Huh SJ; Cho EY; Kim K; Chie EK; Ha SW; Park IA; Ahn SJ; Lee JS; Shin KH; Kwon Y; Kim YB; Suh CO; Koo JS; Kim JH; Jeong BG; Kim IA; Lee JH; Park W
Clin Breast Cancer; 2015 Oct; 15(5):353-61.e1-2. PubMed ID: 25776197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]